A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)
暂无分享,去创建一个
Kazuhiro Sato | T. Ishida | Hiroshi Tanaka | Kosuke Ichikawa | T. Kikuchi | Satoshi Watanabe | H. Yoshizawa | M. Okajima | S. Miura | T. Abe | M. Makino | Kazuhiko Ito | N. Matsumoto | A. Iwashima